ROWSLEY Ltd said it has entered into a facility agreement for S$130 million of new credit facilities.

ROWSLEY announced on Friday that its shareholders have voted in favour of of the proposed healthcare acquisition from "remisier king" Peter Lim, the controlling shareholder of Rowsley...

ROWSLEY on Saturday updated that the consideration for the TMC Life Sciences sale warrants will be RM103.75 million (S$34.81 million) - being their volume-weighted average price traded on Bursa...

REAL estate-focused Rowsley's full-year net loss narrows by 11 per cent to S$56.16 million despite a 9 per cent dip in its revenue. ...

COMMENTARY

IF BILLIONAIRE Peter Lim had wanted to realise the fullest value for the Thomson Medical healthcare group, an initial public offering (IPO) would have been the cleanest way to structure a deal.

ROWSLEY shares surged 2.5 Singapore cents or 22.52 per cent to 13.6 Singapore cents on Monday after it inked a deal to acquire the Thomson Medical healthcare businesses from controlling shareholder...

MAINBOARD-LISTED Rowsley has inked a deal to acquire the Thomson Medical healthcare businesses from tycoon Peter Lim for S$1.6 billion to be paid mostly in stock.

A NEW slate of leadership appointments was announced by Rowsley Ltd on Wednesday in a move to strengthen its core business in design and engineering business.

MAINBOARD-listed Rowsley Limited has appointed Credit Suisse (Singapore) Limited as its financial adviser in the proposed acquisition of the entire issued and paid-up share capital of Sasteria Pte...

MAINBOARD-listed Rowsley has appointed a new chief executive officer with immediate effect.